Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1 2Phase NA 1Phase 3 1Phase 2/3 1Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Tobacco Use Disorder 1Thyroiditis 1Thyroid Neoplasms 1Prostatic Neoplasms 1Precancerous Conditions 1Osteoporosis 1Neoplasm Metastasis 1Lung Neoplasms 1Hypocalcemia 1Hyperthyroidism 1Hyperplasia 1Hyperparathyroidism 1Goiter 1Crohn Disease 1Breast Neoplasms 1Arthritis, Rheumatoid 1

Interventions

Radiosurgery 45Magnetic Resonance Spectroscopy 41Standard of Care 27Radiotherapy 27Exercise 27Brachytherapy 21Early Intervention, Educational 20Surveys and Questionnaires 18Multiparametric Magnetic Resonance Imaging 17Magnetic Resonance Imaging 16Androgen Antagonists 16Blood Specimen Collection 15Interviews as Topic 14Radiotherapy, Intensity-Modulated 13Methods 13Therapeutics 12Psychiatric Rehabilitation 12Educational Status 12Biopsy 12Specimen Handling 10Resistance Training 10Prostatectomy 9Diet Therapy 9Counseling 9gallium 68 PSMA-11 8Radiation 8Proton Therapy 8Practice Guidelines as Topic 8High-Intensity Interval Training 7Electroporation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Prostatic Neoplasms × Calcitriol × Clear all
NCT00482157 2022-03-03

Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance

Stanford University

Phase NA Withdrawn
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡